MCMedicalCodingSoftware
Free trial
3E0J30M

3E0J30M — Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce Antneo, Moncln Ab, in Bil/Panc Tract, Perc

How 3E0J30M is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. JBody partThe specific site
  5. 3ApproachHow the site was reached
  6. 0DeviceWhat was left in place, if anything
  7. MQualifierA further distinction where one applies

Codes near 3E0J30M

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E0H8GCIntroduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0H8HZIntroduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0H8KZIntroduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0H8NZIntroduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0H8SFIntroduction of Other Gas into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0H8TZIntroduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic
  • 3E0J304Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J305Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J30MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J328Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J329Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J33ZIntroduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J36ZIntroduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J37ZIntroduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3BZIntroduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
  • 3E0J3HZIntroduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach
ICD-10-PCSFY2026